Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease

2018 ◽  
Vol 20 (5) ◽  
pp. e12929 ◽  
Author(s):  
Jose O. Reusing ◽  
Emanoela B. Feitosa ◽  
Fabiana Agena ◽  
Lígia C. Pierrotti ◽  
Luiz S. F. Azevedo ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplant ◽  
Induction Therapy ◽  
Therapy Outcome ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Cmv Disease

scholarly journals FP873IMMUNOGLOBULIN INDUCTION THERAPY IN RENAL TRANSPLANT RECIPIENTS - FIVE YEAR DATA OF A PROSPECTIVE RANDOMIZED PILOT STUDY

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii369-iii369 ◽  
Author(s):  
Rolf Weimer ◽  
Bogumila Bartylak ◽  
Anne Staak ◽  
Fabrice Renner ◽  
Caner Suesal ◽  
...  
Keyword(s):  
Pilot Study ◽  
Renal Transplant ◽  
Induction Therapy ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

Risk Factors in the Development of Cytomegalovirus-Related Pneumonia in Renal Transplant Recipients

1983 ◽  
Vol 148 (6) ◽  
pp. 1121-1121 ◽  
Author(s):  
P. K. Peterson ◽  
H. H. Balfour ◽  
D. S. Fryd ◽  
R. Ferguson ◽  
R. Kronenberg ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

BK virus replication in renal transplant recipients: Analysis of potential risk factors may contribute in reactivation

2017 ◽  
Vol 96 ◽  
pp. 7-11 ◽  
Author(s):  
Mohammad Shenagari ◽  
Ali Monfared ◽  
Hadise Eghtedari ◽  
Aydin Pourkazemi ◽  
Tolou Hasandokht ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplant ◽  
Virus Replication ◽  
Potential Risk ◽  
Bk Virus ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Potential Risk Factors

scholarly journals Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients

2010 ◽  
Vol 26 (6) ◽  
pp. 2013-2017 ◽  
Author(s):  
F. Eitner ◽  
I. A. Hauser ◽  
O. Rettkowski ◽  
T. Rath ◽  
K. Lopau ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Pneumocystis Jiroveci ◽  
Pneumocystis Jiroveci Pneumonia

scholarly journals Underlying Causes and Risk Factors of Chronic Renal Allograft Dysfunction Among Renal Transplant Recipients

Acta Medica ◽  
2021 ◽  
pp. 1-10
Author(s):  
Göksel Güven ◽  
Şeref Rahmi Yılmaz ◽  
Tolga Yıldırım ◽  
Fazıl Tuncay Akı ◽  
Yunus Erdem
Keyword(s):  
Risk Factors ◽  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Chronic Allograft Dysfunction ◽  
Specific Antibodies ◽  
Panel Reactive Antibody ◽  
Allograft Dysfunction ◽  
Donor Specific Antibodies ◽  
Reactive Antibody

Objective: Dialysis or renal transplantation are the two treatment options for end-stage renal disease patients. Renal transplantation from an appropriate donor increases survival and quality of life compared to treatment with dialysis. Recent advances in immunosuppressive therapy have significantly improved the success in 1-year graft survival. However, the long-term graft survival remains the same. Therefore, we aimed to determine the underlying causes and risk factors of chronic allograft dysfunction in renal transplant recipients. Materials and Methods: From 2000 to 2012, all consecutive renal transplant recipients followed in our tertiary referral center who underwent renal biopsy due to an increase in serum creatinine level were enrolled. Etiologies of chronic allograft dysfunction were assessed according to pathologic results of renal biopsy specimens and laboratory findings. The immunological and non-immunological risk factors of chronic allograft dysfunction were screened and recorded retrospectively. Results: Eighty (80) renal transplant recipients with a mean age of 38±10 years were included in the study. Delayed graft function (p=0.007), history of acute rejection (p<0.001), positive panel reactive antibody (p=0.033) (Class I (p=0.013), Class II (p=0.006)), positive donor specific antibodies (p=0.001), number of recurrent acute rejections (p<0.001), number of human leukocyte antigens mismatches (p=0.051), cold ischemia time (p=0.001) were found to be risk factors for chronic allograft dysfunction. The donor specific antibodies positivity (p<0.001) and the panel reactive antibody positivity (Class I (p=0.003), Class II (p=0.001)) were significantly higher in patients with antibody mediated rejection than patients without antibody mediated rejection (p=0.002). Conclusion: Delayed graft function, presence and the number of acute rejections, increased cold ischemia time, panel reactive antibody positivity, donor specific antibodies positivity, and the number of human leukocyte antigens mismatches were risk factors for chronic allograft dysfunction.

Sign in / Sign up

Export Citation Format

Share Document